LifeVantage Corporation



$5.59Share Price
$79 MMarket Cap
5.2%EBIT / EV
6.3%FCF / EV
36.4%Cash ROIC
-2.4%3yr Avg Revenue Growth
1.54Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 5.2% ranks as Average.
check mark The Free Cash Flow / Enterprise Value of 6.3% ranks as Above Average.
check mark The Return on Invested Capital Value of 30.3% ranks as Very High.
check mark The Cash Return on Capital Value of 36.4% ranks as Very High.
x mark The 3 Year Average Revenue Growth Value of -2.4% ranks as Below Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 1.54.

Company Description

LifeVantage Corp. is a science-based company. It engages in the identification, research, development, manufacture and distribution of an advanced nutraceutical dietary supplement, including products Protandim; the Nrf2 Synergizer; Axio, anti-aging skin care product; LifeVantage TrueScience; and Canine Health. The firm operates through the Americas; and Asia or Pacific geographical segments. It currently focuses on oxidative stress solutions, particularly the activation of nuclear factor which relates to cardiovascular, central nervous system, inflammatory and metabolic diseases as well as other health related disorders. The company was founded in June 1988 and is headquartered in Sandy, UT.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.